Clinical Trials Browser

Interventional × Neurocytoma × Clear all

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT04923126 2026-02-04

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Phase 1/2 Recruiting

132 enrolled

CNS

Astrocytoma, Ganglioneuroma, Oligodendroglioma, Neoplasms, Neuroepithelial, Ganglioglioma, Neurocytoma

NCT02684058 2023-12-13

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Phase 2 Completed

151 enrolled 45 charts 1 FDA

CNS

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma, Neurocytoma

NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Phase 2 Completed

34 enrolled 6 charts

CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

Clinical Trials

Pediatric Long-Term Follow-up and Rollover Study

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Antineoplaston Therapy in Treating Children With Brain Tumors

Antineoplaston Therapy in Treating Patients With Brain Tumors